Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencing-Reference-Cited by-同舟云学术

Identification of RET fusions in a Chinese multicancer retrospective analysis by next‐generation sequencing

Published:2021-11-15 Issue:1 Volume:113 Page:308-318
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Science

Author:

Shi Minke¹,Wang Weiran²^ORCID,Zhang Jinku³,Li Bobo⁴,Lv Dongxiao⁵,Wang Danhua²,Wang Sizhen⁶,Cheng Dezhi⁷,Ma Tonghui²

Affiliation:

1. Department of Thoracic and Cardiovascular Surgery The Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing China

2. Department of Translational Medicine Genetron Health (Beijing) Technology, Co. Ltd. Beijing China

3. Department of Pathology Key Laboratory of Molecular Pathology and Early Diagnosis of Tumor in Hebei Province The First Centre Hospital of Baoding Baoding China

4. Department of Thoracic Surgery Shandong Cancer Hospital Affiliated to Shandong University Jinan China

5. Tumor Research and Therapy Center Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan China

6. Genetron Health (Beijing) Technology, Co. Ltd. Beijing China

7. Department of Thoracic Surgery The First Affiliated Hospital of Wenzhou Medical University Wenzhou China

Funder

Wenzhou Medical University

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.15181

Reference64 articles.

1. Activation of a novel human transforming gene, ret, by DNA rearrangement

2. RET and NTRK1 proto-oncogenes in human diseases

3. Targeting Multiple Signaling Pathways as a Strategy for Managing Prostate Cancer: Multifocal Signal Modulation Therapy

4. Novel Targets in Non-Small Cell Lung Cancer: ROS1 and RET Fusions

5. KIF5B-RET fusion kinase promotes cell growth by multilevel activation of STAT3 in lung cancer

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical relevance and druggability of sole reciprocal kinase fusions: A large‐scale study;Cancer Medicine;2024-09

2. Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-center Retrospective Cohort Study in a Chinese Population;Thyroid®;2024-08-30

3. Efficacy and safety of pyrotinib combined with albumin‐bound paclitaxel as first‐line treatment for HER2‐positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single‐arm, phase 2 prospective clinical trial;Clinical and Translational Medicine;2024-05

4. Concurrent KRAS p.G12C mutation and ANK3::RET fusion in a patient with metastatic colorectal cancer: a case report;Diagnostic Pathology;2024-03-27

5. Clinicopathological analysis of thyroid carcinomas with the RET and NTRK fusion genes: characterization for genetic analysis;Virchows Archiv;2024-03-12